Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HKN8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 10 | 14 | PF00656 | 0.518 |
CLV_C14_Caspase3-7 | 34 | 38 | PF00656 | 0.705 |
CLV_C14_Caspase3-7 | 50 | 54 | PF00656 | 0.545 |
CLV_PCSK_SKI1_1 | 111 | 115 | PF00082 | 0.376 |
CLV_PCSK_SKI1_1 | 90 | 94 | PF00082 | 0.423 |
DEG_SPOP_SBC_1 | 30 | 34 | PF00917 | 0.558 |
DOC_CYCLIN_RxL_1 | 87 | 96 | PF00134 | 0.438 |
DOC_CYCLIN_yCln2_LP_2 | 113 | 119 | PF00134 | 0.365 |
DOC_MAPK_MEF2A_6 | 127 | 136 | PF00069 | 0.525 |
DOC_PP1_RVXF_1 | 109 | 115 | PF00149 | 0.389 |
DOC_PP4_FxxP_1 | 68 | 71 | PF00568 | 0.354 |
DOC_USP7_MATH_1 | 123 | 127 | PF00917 | 0.327 |
DOC_USP7_MATH_1 | 26 | 30 | PF00917 | 0.656 |
DOC_USP7_MATH_1 | 31 | 35 | PF00917 | 0.671 |
DOC_USP7_MATH_1 | 39 | 43 | PF00917 | 0.668 |
DOC_USP7_MATH_1 | 62 | 66 | PF00917 | 0.492 |
LIG_14-3-3_CanoR_1 | 5 | 12 | PF00244 | 0.492 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.682 |
LIG_BRCT_BRCA1_1 | 64 | 68 | PF00533 | 0.458 |
LIG_BRCT_BRCA1_1 | 76 | 80 | PF00533 | 0.294 |
LIG_CtBP_PxDLS_1 | 116 | 120 | PF00389 | 0.511 |
LIG_FHA_1 | 103 | 109 | PF00498 | 0.409 |
LIG_FHA_1 | 46 | 52 | PF00498 | 0.515 |
LIG_LIR_Apic_2 | 16 | 21 | PF02991 | 0.556 |
LIG_LIR_Apic_2 | 65 | 71 | PF02991 | 0.493 |
LIG_SH2_STAP1 | 76 | 80 | PF00017 | 0.377 |
LIG_SH2_STAT5 | 107 | 110 | PF00017 | 0.532 |
LIG_SH3_3 | 18 | 24 | PF00018 | 0.472 |
LIG_SUMO_SIM_par_1 | 115 | 121 | PF11976 | 0.382 |
MOD_CK1_1 | 29 | 35 | PF00069 | 0.707 |
MOD_CK1_1 | 7 | 13 | PF00069 | 0.646 |
MOD_CK1_1 | 72 | 78 | PF00069 | 0.395 |
MOD_CK2_1 | 11 | 17 | PF00069 | 0.568 |
MOD_CK2_1 | 123 | 129 | PF00069 | 0.368 |
MOD_GlcNHglycan | 13 | 16 | PF01048 | 0.526 |
MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.709 |
MOD_GlcNHglycan | 33 | 36 | PF01048 | 0.759 |
MOD_GlcNHglycan | 41 | 44 | PF01048 | 0.687 |
MOD_GlcNHglycan | 71 | 74 | PF01048 | 0.412 |
MOD_GlcNHglycan | 76 | 79 | PF01048 | 0.383 |
MOD_GSK3_1 | 25 | 32 | PF00069 | 0.749 |
MOD_GSK3_1 | 7 | 14 | PF00069 | 0.600 |
MOD_N-GLC_1 | 5 | 10 | PF02516 | 0.708 |
MOD_PKA_2 | 4 | 10 | PF00069 | 0.600 |
MOD_Plk_1 | 101 | 107 | PF00069 | 0.419 |
MOD_Plk_2-3 | 115 | 121 | PF00069 | 0.382 |
MOD_Plk_4 | 102 | 108 | PF00069 | 0.411 |
MOD_Plk_4 | 62 | 68 | PF00069 | 0.558 |
MOD_SUMO_for_1 | 132 | 135 | PF00179 | 0.407 |
MOD_SUMO_rev_2 | 120 | 128 | PF00179 | 0.482 |
TRG_Pf-PMV_PEXEL_1 | 111 | 115 | PF00026 | 0.388 |
TRG_Pf-PMV_PEXEL_1 | 90 | 94 | PF00026 | 0.514 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I4I3 | Leptomonas seymouri | 62% | 100% |
A0A0S4IYR4 | Bodo saltans | 41% | 95% |
A0A1X0NRU4 | Trypanosomatidae | 38% | 100% |
A0A3R7MFQ9 | Trypanosoma rangeli | 44% | 100% |
A0A3S7X5R6 | Leishmania donovani | 74% | 100% |
A4I869 | Leishmania infantum | 74% | 100% |
D0AAD8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
E9B327 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 70% | 100% |
Q4Q527 | Leishmania major | 71% | 96% |